Get the Stockscreener App
17.59
1.21%
0.21
After Hours:
17.57
-0.02
-0.11%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.59, with a volume of 45.81M.
It is up +1.21% in the last 24 hours and up +1.56% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.38
Open:
$17.25
24h Volume:
45.81M
Relative Volume:
1.04
Market Cap:
$33.70B
Revenue:
$15.01B
Net Income/Loss:
$1.43B
P/E Ratio:
23.64
EPS:
0.744
Net Cash Flow:
$1.63B
1W Performance:
+0.51%
1M Performance:
+1.56%
6M Performance:
-18.53%
1Y Performance:
-17.15%
1-Day Range:
$17.25
$17.70
1-Week Range:
$17.14
$17.70
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.59 | 33.30B | 15.01B | 1.43B | 1.63B | 0.744 |
|
PG
Procter Gamble Co
|
155.32 | 356.01B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
69.15 | 149.97B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
93.15 | 74.07B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
116.27 | 42.80B | 14.42B | -930.00M | 1.05B | -2.5832 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Villere ST Denis J & Co. LLC Buys Shares of 681,540 Kenvue Inc. $KVUE - MarketBeat
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal - MSN
Shareholders approve Kimberly-Clark’s $48B purchase of Tylenol maker - The Business Journals
Kenvue (NYSE:KVUE) Updates Operations Within Consumer Health Sector - Kalkine Media
New York State Common Retirement Fund Sells 1,017,349 Shares of Kenvue Inc. $KVUE - MarketBeat
Yacktman Asset Management LP Sells 247,210 Shares of Kenvue Inc. $KVUE - MarketBeat
Mirae Asset Global Investments Co. Ltd. Reduces Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Federated Hermes Inc. - MarketBeat
Thrivent Financial for Lutherans Buys 319,309 Shares of Kenvue Inc. $KVUE - MarketBeat
Yielding 4%, Is Kenvue Stock a Buy in 2026? - TIKR.com
Assessing Kenvue (KVUE) Valuation As Recent Share Momentum Contrasts With Longer Term Returns - Yahoo Finance
Kenvue Holders Weigh Risks As Kimberly-Clark Deal Clears Key Hurdle - Yahoo Finance
1 Super-Safe High-Yield Dividend King Stock to Buy Even if There's a Stock Market Sell-Off in 2026 - AOL.com
Rate Hike: Can Kenvue Inc expand into new marketsOptions Play & AI Driven Price Predictions - baoquankhu1.vn
Coastal Bridge Advisors LLC Has $424,000 Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Keybank National Association OH - MarketBeat
Great Lakes Advisors LLC Purchases 85,901 Shares of Kenvue Inc. $KVUE - MarketBeat
Shareholders Overwhelmingly Approve Kimberly-Clark’s Acquisition of Kenvue - New Jersey Business Magazine
Kimberly-Clark’s $49 Billion Acquisition of Tylenol’s Parent Company Kenvue Approved - D Magazine
Jefferies downgrades Kenvue as deal approval leaves limited upside - Investing.com
Shareholders Approve Kimberly-Clark’s Acquisition of Kenvue - Beauty Packaging
Here Are Friday’s Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More - AOL.com
Kimberly-Clark moves forward with Kenvue acquisition following shareholder approval - Tissue Online North America
Jefferies Downgrades Kenvue to Hold From Buy, Adjusts Price Target to $18 From $23 - marketscreener.com
Jefferies downgrades Kenvue stock to Hold on limited upside after merger vote - Investing.com Australia
Jefferies downgrades Kenvue stock to Hold on limited upside after merger vote By Investing.com - Investing.com South Africa
Kenvue Inc. Declares Quarterly Dividend of $0.2075 per Share - Intellectia AI
ORS Lookalikes and Regulatory Failure: How Brands Keep Putting Children at Risk - Frontline Magazine
Kimberly-Clark and Kenvue shareholders approve acquisition deal By Investing.com - Investing.com South Africa
Kenvue Shareholder Meeting Shows Strong Support To Accept Kimberly-Clark’s Nearly $50Bn Offer - Citeline News & Insights
Kimberly-Clark shareholders approve acquisition of Kenvue - WTAQ
Shareholders Approve Kimberly-Clark’s $40B Acquisition of Tylenol Maker Kenvue - Dallas Innovates
Kenvue shareholders overwhelmingly approve Kimberly-Clark merger plan - TipRanks
Shareholders approve $48.7B Kimberly-Clark, Kenvue deal - NJBIZ
Kenvue shareholders approve Kimberly-Clark?s acquisition of the Company - marketscreener.com
Kimberly-Clark (KMB) investors approve stock issuance for planned Kenvue merger - Stock Titan
Peering Into Kenvue Inc's Recent Short Interest - Benzinga
Shareholders approve Kimberly-Clark purchase of Tylenol parent company - WFMJ.com
Kimberly-Clark’s $48.7B acquisition of Kenvue approved by both companies’ shareholders - ROI-NJ
From diapers to Tylenol: The household products mega-merger that will serve half the world's population - MSN
Kenvue stock price barely budges after Kimberly-Clark buyout vote — what KVUE traders watch next - TechStock²
Kimberly-Clark and Kenvue shareholders back $50bn merger - The Grocer
Kimberly-Clark (KMB) Shareholders Approve Acquisition of Kenvue - GuruFocus
KVUE: Merger and advisory compensation proposals were approved with strong shareholder participation - TradingView
Kimberly-Clark and Kenvue shareholders approve acquisition deal - Investing.com
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue - PR Newswire
Kenvue Inc. $KVUE Position Trimmed by Bank of New York Mellon Corp - MarketBeat
Kenvue appoints Madhav Nayak as APAC CMO - Campaign Asia
Kenvue (KVUE) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Kimberly-Clark Reshapes Portfolio With Kenvue Deal And Dividend Focus - simplywall.st
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):